18 results
8-K
EX-99.1
ADVM
Adverum Biotechnologies Inc
9 May 24
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
4:10pm
paradigms for debilitating ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around
8-K
EX-99.1
ADVM
Adverum Biotechnologies Inc
18 Mar 24
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
4:08pm
ocular diseases, Adverum aspires to transform the standard of care, preserve vision, and create a profound societal impact around the globe. For more
8-K
EX-99.1
ggzdg
9 Nov 23
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
4:07pm
8-K
EX-99.1
mlwg8126q2
10 Aug 23
Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results
4:09pm
8-K
EX-99.1
4axqc bf1
11 May 23
Adverum Biotechnologies Reports First Quarter 2023 Financial Results
4:10pm
PRE 14A
6zljff wtdb1s
14 Apr 23
Preliminary proxy
6:03am
8-K
EX-99.1
dj9uin3w
30 Mar 23
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update
4:09pm
8-K
EX-99.1
wtchn jw5lt9217g8
10 Nov 22
Adverum Biotechnologies Reports Third Quarter 2022 Financial Results
4:14pm
8-K
EX-99.1
w70a38
11 Aug 22
Results of Operations and Financial Condition
4:10pm
- Prev
- 1
- Next